Holding could still work as a mean-reversion trade if EWJ stabilizes around the next support zone near $87.82–$87.99 after the earlier $89.13–$89.26 shelf broke. Oversold conditions, a turn higher in short-term momentum and rising weekly RSI offer tentative signs of stabilization; if price reclaims the nearby $88.47 value-area low, there may be time within the intended holding period for a move toward the $93–$95 value area. The case also points to a possible ex-dividend catalyst, BoJ liquidity support and sector-wide weakness rather than an EWJ-specific breakdown, with peers not diverging in some accounts. It is nevertheless weakened by the untested resistance and mixed momentum readings, and depends on support holding and a reversal emerging; the key uncertainty is whether these early signs can overcome the broken shelf and broader risk-off pressure.
Exiting could be justified because the $89.13–$89.26 support shelf that anchored the mean-reversion thesis has failed, and price remains below the value-area low without reclaiming nearby resistance or showing a convincing reversal. Falling daily RSI and MACD, short-biased momentum and deteriorating participation in some readings point to continued weakness, while a volatile or bearish US-equity regime and, in one account, a firm dollar and weak peers add pressure. The path back to the target now depends on clearing several unaccepted resistance levels, and the expected catalysts may be nondirectional or insufficient to offset global risk concerns; the BoJ support and upcoming dividend date have not clearly reversed the decline. The main uncertainty is whether the current support zone can still produce a rebound before further downside toward lower support.
The entry support shelf failed. Price is below the value-area low and weekly resistance, momentum is negative on every horizon, regime risk is high, and target progress is -18.5%. The thesis needed a reclaim of nearby resistance and has instead failed.
The support shelf at 89.13-89.26 was lost. Price is below the value-area low and weekly resistance, with momentum negative across horizons and target progress at -18.5%. The mean-reversion thesis has not materialized and the path to 93-97 is blocked by multiple barriers.
The entry support shelf failed. Price is below the value-area low and weekly resistance, momentum is negative on every horizon, regime risk is high, and target progress is -18.5%. The thesis needed a reclaim of nearby resistance and has instead failed.
▼ Click to expandThe daily RSI is oversold at 34 and price is near the lower Bollinger band, with support at 87.82 and the stop at 86.80 not breached. A bounce could reclaim 89.40 and head toward the 93-95 value area, and the remaining R:R is 7.1.
▼ Click to expandThe original thesis is invalidated. The core premise — that the $89.13-$89.26 support shelf would hold for a mean-reversion bounce — has been broken. Price is at $88.08, below entry, below the broken support, and below the value area low. Daily momentum is deteriorating (RSI 34.38 falling, MACD negative/falling). The US equity regime is volatile/bearish with risk elevated. The unhedged yen exposure is underperforming the hedged alternative. No reversal structure or supportive catalyst has emerged. Continuing to hold risks further drawdown toward the $86.80 stop or the weekly support at $84.90.
The original thesis support shelf at $89.13-$89.26 has been broken and price has failed to reclaim it. Price at $88.08 is -1.6% below entry with deteriorating daily momentum (RSI 34.38 falling, MACD negative/falling). The value area low at $88.47 has been rejected to the downside. The US equity regime is volatile/bearish with risk elevated to high. No reversal structure or supportive catalyst is present. The core condition for the mean-reversion thesis is invalidated.
The original thesis is invalidated. The core premise — that the $89.13-$89.26 support shelf would hold for a mean-reversion bounce — has been broken. Price is at $88.08, below entry, below the broken support, and below the value area low. Daily momentum is deteriorating (RSI 34.38 falling, MACD negative/falling). The US equity regime is volatile/bearish with risk elevated. The unhedged yen exposure is underperforming the hedged alternative. No reversal structure or supportive catalyst has emerged. Continuing to hold risks further drawdown toward the $86.80 stop or the weekly support at $84.90.
▼ Click to expandThe position could still be held if the $87.82 support holds and price stages a reversal bounce, reclaiming the value area low at $88.47 and eventually the broken $89.13-$89.26 shelf. The remaining R:R of 7.1x to the $97.18 target is large, and 77 calendar days remain until lifecycle expiry. The weekly RSI is rising slightly (+1.61 over 3 bars), suggesting some stabilization at the weekly timeframe.
▼ Click to expandThe original thesis is invalidated by a break of critical support ($89.13–$89.26), failed momentum confirmation, deteriorating participation, and regime drift that breaks the original path to target. The position is below entry and below support, with no evidence of acceptance or reversal. Risk/reward has deteriorated materially, and the remaining path to target is no longer feasible.
The original thesis is invalidated by a break of critical support, failed momentum confirmation, deteriorating participation, and regime drift that breaks the original path to target. The position is below entry and below support, with no evidence of acceptance or reversal. The risk/reward has deteriorated materially, and the remaining path to target is no longer feasible.
The original thesis is invalidated by a break of critical support ($89.13–$89.26), failed momentum confirmation, deteriorating participation, and regime drift that breaks the original path to target. The position is below entry and below support, with no evidence of acceptance or reversal. Risk/reward has deteriorated materially, and the remaining path to target is no longer feasible.
▼ Click to expandOversold conditions (RSI 34.38) could theoretically attract dip-buyers. BoJ liquidity support remains a tailwind for Japan equities, though it has not translated into EWJ strength. Dividend ex-date (Dec 15) is approaching, which might provide temporary support. Cross-asset peers (DXJ, BBJP) are outperforming, but EWJ has not confirmed participation.
▼ Click to expandIntraday discovery triggered reanalysis on EWJ. Verdict: EXIT (3/3 EXIT). Conviction: 47.